TNXP
Tonix Pharmaceuticals Holding Corp.
NASDAQ · Healthcare · Biotechnology · US
$5.11
−1.54%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 0.91x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.39x
- Price / sales
- 3.01x
- Price / cash flow
- -0.57x
Enterprise value
- Enterprise value
- -$87.3M
- EV / sales
- -3.00x
- EV / EBITDA
- 0.55x
- EV / EBIT
- 0.53x
- Market cap
- $87.6M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026